about
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaA prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma.Visceral artery aneurysms in liver transplant candidates and in patients after liver transplantation.Liver retransplantation in adults: the largest multicenter Italian study.Early and late de novo tumors after liver transplantation in adults: the late onset of bladder tumors in men.Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.Holmium Intraductal Laser Lithotripsy of Biliary Stones in Liver Grafts.Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.Robotic surgery of the liver: Italian experience and review of the literature.Portal vein arterialization for hepatic artery thrombosis in liver transplantation: a case report, Doppler-ultrasound aspects, and review of the literature.Sent Liver Grafts Do Not Have a Detrimental Impact on Post-transplant Outcome.Fulminant multiorgan failure due to varicella zoster virus and HHV6 in an immunocompetent adult patient, and anhepatia.A new duodenal rendezvous technique for biliary cannulation in patients with T-tube after orthotopic liver transplantation (with video).Negative Pressure Wound Treatment of Infections Caused By Extensively Drug-Resistant Gram-Negative Bacteria After Liver Transplantation: Two Case Reports.Extended survival of patients with persistently suppressed hepatitis B transplanted for hepatocellular carcinoma.Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation.Thrombosis after liver transplantation for hepatocellular carcinoma.Metabolic syndrome after liver transplantation: short-term prevalence and pre- and post-operative risk factors.Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching.Inappropriate pemoline therapy leading to acute liver failure and liver transplantation.A risk score and a flowchart for liver retransplantation.Surveillance and treatment of liver transplant recipients for candidiasis and aspergillosis.Combined liver and kidney transplantation: a single-center experience.Hyperbilirubinemia after liver transplantation: the role of coupled plasma filtration adsorption.Cytotoxic T-lymphocyte antigen-4 A49G polymorphism is associated with susceptibility to and severity of alcoholic liver disease in Italian patients.No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.Role of lamivudine in the posttransplant prophylaxis of chronic hepatitis B virus and hepatitis delta virus coinfection.Infusion of autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for prevention of EBV-related lymphoproliferative disorder in solid organ transplant recipients with evidence of active virus replication.Hepatitis B and C virus-induced diseases and acute rejection after liver transplantation.Hepatitis C virus infection and liver transplantation.Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients.Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma.A follow-up study of patients with Zollinger-Ellison syndrome in the period 1966-2002: effects of surgical and medical treatments on long-term survival.ERCP and short-term stent-trial in patients with anastomotic biliary stricture following liver transplantation.Transarterial embolization with microspheres in the treatment of monofocal HCC.Effects of liver transplantation on the nutritional status of patients with cystic fibrosis.Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
P50
Q28478709-CD5AB74D-C875-4C2B-AEA5-7EDD41B2ACEAQ33575450-5C16CDBF-E5C8-4B09-80A7-C03157AFC986Q34117691-B47FF7D9-CB93-4841-AD0C-19EE9075069CQ34447307-CC3FB3DA-93BC-4126-9EC6-EDA45649E6BFQ34778656-CF243AC7-5C40-4CA5-BD0A-771BEDF537B4Q35038756-D27F201D-9C11-4145-90DA-8D4C714E8126Q35997868-01DBDAEF-0F0E-405D-86F0-C6FC34056F8BQ36381360-061EA9AC-70CB-4A92-8AA9-5E020569EAC9Q37265406-AA938653-FD88-4B2C-AC41-3981615470C9Q37763758-6E004714-9FD3-4730-8E97-EEFEE55D75E2Q38665901-7CBEC4EA-FB59-4AA8-AF81-0EE42664A487Q40323563-CD221C49-7F27-4E7C-A814-58F6BBFCAB02Q40668819-41DED7F3-E7C8-4946-B3F4-807A00DF20CCQ41004904-B108BEFF-6F36-4184-9E8E-427F14A13B1BQ41384111-F18B08F2-159E-42E4-9745-DAAE3CA27D4EQ42230987-CBCEE9CA-895B-4FEB-AC19-2EC3207F0837Q42259673-A4F3D632-FBB9-43A6-B71A-79B21A5D2459Q42657773-A48C102C-F181-4FD9-82ED-28A0BF6CBC4CQ43026378-A9E731D0-26F4-4C89-A54D-91F6B3097BCDQ43565726-D519A3FF-5CA4-4D59-94DD-81EC22288F9EQ43843530-0A4C419A-6A38-4D53-BBC8-A48F7CCD78E1Q44073518-B631E452-561A-4813-8B12-DF6B4A6DD15EQ44101702-313910EE-D5A4-46CF-9029-4D46B741BE3FQ44204150-0411DFFF-C74C-4980-A8AB-ACAF8FD0C9A0Q44256986-E56EA073-EA68-4677-B421-8D6DD1283F11Q44788448-675472FC-AFC5-4649-BEE1-0D19333C57F5Q44945308-5D3C6EB8-903E-41D9-A80E-B21D657FF881Q45250862-B543C934-8EC5-4DCD-B08C-A6BC0C794889Q45388079-B73952FE-8D65-4B86-A922-D21879ABB526Q45403711-ED528813-70BA-4C56-A108-3B5FC6D081D1Q45733331-C6CFE47B-8048-4382-B77E-CD19BE421F97Q45752173-CDB8E8C5-32F5-49E8-8670-40DE0BFB6296Q45844522-DE2EFBF5-A54C-4904-AE4A-66656679EE3BQ46243464-D0E71455-FF2D-4558-B1FA-1AB7925A31A4Q46334695-611D6F30-DCE5-4C12-9BF2-83156B457722Q46426134-CF1704A9-9EFE-4E87-9EF3-BB3F06DF076BQ47310320-321CD2A6-BBEC-4509-B724-0B4C431697D2Q47750627-8D8C0EB1-BFFC-47B4-A262-15B2DA4721CCQ47854587-BDF26315-AC39-460C-A21C-094B34687DFCQ47939869-64A42A60-826F-4D0B-BFD8-3C95B9CC701A
P50
description
Italian hepatologist
@en
onderzoeker
@nl
հետազոտող
@hy
name
Giorgio Rossi
@ast
Giorgio Rossi
@en
Giorgio Rossi
@es
Giorgio Rossi
@sl
type
label
Giorgio Rossi
@ast
Giorgio Rossi
@en
Giorgio Rossi
@es
Giorgio Rossi
@sl
prefLabel
Giorgio Rossi
@ast
Giorgio Rossi
@en
Giorgio Rossi
@es
Giorgio Rossi
@sl
P1053
M-3445-2015
P106
P1153
8943901100
P21
P31
P3829
P496
0000-0002-5588-1306